Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 21 to 30 of 34

TitleReference numberPublishedLast updated
Dapagliflozin in combination therapy for treating type 2 diabetesTA288
Dapagliflozin in triple therapy for treating type 2 diabetesTA418
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetesTA390
MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetesMIB51
Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar)ESNM64
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo)ESNM65
Type 2 diabetes: insulin degludec/liraglutide (Xultophy)ESNM60
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesIPG518
Empagliflozin in combination therapy for treating type 2 diabetesTA336
Canagliflozin in combination therapy for treating type 2 diabetesTA315

Results per page

  1. 10
  2. 25
  3. 50
  4. All